Erratum to: GLS-409, an Antagonist of Both P2Y1 and P2Y12, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation (Scientific Reports, (2018), 8, 1, (14529), 10.1038/s41598-018-32797-1)

Elena Smolensky Koganov, Alan D. Michelson, Ivan B. Yanachkov, Milka I. Yanachkova, George E. Wright, Karin Przyklenk, Andrew L. Frelinger

Research output: Contribution to journalComment/debate

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

Original languageEnglish
Article number17580
JournalScientific Reports
Volume8
Issue number1
DOIs
StatePublished - Dec 1 2018

Fingerprint

Dive into the research topics of 'Erratum to: GLS-409, an Antagonist of Both P2Y1 and P2Y12, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation (Scientific Reports, (2018), 8, 1, (14529), 10.1038/s41598-018-32797-1)'. Together they form a unique fingerprint.

Cite this